Interleukin 17A inhibitor secukinumab in the treatment of patients with psoriatic arthritis

N. A. Shostak; D. Yu. Andriyashkina; A. S. Dvornikov; N.  M. Babadaev; D. V. Somov

The Clinician
Klinicist

ISSN 1818-8338 (Print)

User

eng | рус

The Clinician

Advanced search

Archives

Download this PDF file

Fullscreen

For citations:

Shostak N.A., Andriyashkina D.Yu., Dvornikov A.S., Babadaev N.M., Somov D.V. Interleukin 17A inhibitor secukinumab in the treatment of patients with psoriatic arthritis. The Clinician. 2022;16(2):27-39. (In Russ.) https://doi.org/10.17650/1818-8338-2022-16-2-K665

Views PDF (Rus): 371

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 1818-8338 (Print)

* not an advertisement

Indexing Databases

* not an advertisement

Popular articles

Editor-in-Chief

Shostak N.A.

Article Tools

Finding References

Email this article (Login required)

Email the author (Login required)

About the Authors

N. A. Shostak
Department of Faculty Therapy named after Academician A. I. Nesterov, Pirogov Russian National Research Medical University, Ministry of Health of Russia
Russian Federation